How Diabetes Affects Cataract Surgery
Diabetic patients develop cataracts earlier and more aggressively than non-diabetic patients. Fluctuations in blood sugar cause changes in the lens that accelerate clouding. But the cataract itself is often the simpler problem to solve. The real complexity comes from what diabetes does to the rest of the eye.
Diabetic retinopathy, diabetic macular edema (DME), compromised blood vessel integrity, and a tendency toward more aggressive postoperative inflammation all change the surgical equation. A surgeon who only looks at the cataract is missing the bigger picture.
Diabetic Retinopathy Screening
Before any diabetic patient has cataract surgery, I perform a thorough retinal evaluation. The severity of diabetic retinopathy directly affects my surgical planning:
- No retinopathy or mild NPDR: Cataract surgery can typically proceed with standard timing. I still monitor the retina carefully after surgery, as the surgical inflammation can occasionally accelerate retinopathy progression.
- Moderate to severe NPDR: The retina needs attention before or alongside cataract surgery. I may coordinate with a retina specialist for pan-retinal photocoagulation or anti-VEGF injections to stabilize the retina before proceeding with cataract removal.
- Proliferative diabetic retinopathy (PDR): Active PDR significantly increases the risk of surgical complications including vitreous hemorrhage and neovascular glaucoma. The retinopathy must be treated and stabilized before cataract surgery, except in cases where the cataract is so dense that it prevents adequate retinal treatment.
Diabetic Macular Edema
DME is swelling in the central retina caused by leaking blood vessels. It is the most common cause of vision loss in diabetic patients. If a patient has active DME at the time of cataract surgery, the surgery can worsen it. Conversely, untreated DME limits the visual improvement that cataract surgery can deliver.
My approach is to screen for DME with OCT imaging before surgery. If DME is present, I treat it with anti-VEGF injections before proceeding with cataract surgery. This staged approach protects the macula and maximizes the visual benefit of cataract removal. In some cases, I may administer an anti-VEGF injection at the time of cataract surgery to provide additional protection.
Lens Selection for Diabetic Patients
Diabetes affects lens implant selection significantly:
- Multifocal IOLs are generally not ideal for patients with diabetic retinopathy or macular edema, as these conditions reduce contrast sensitivity and multifocal lenses compound that effect.
- Monofocal or EDOF lenses typically deliver the best functional vision for diabetic patients.
- Toric IOLs to reduce astigmatism are still appropriate if the patient has stable astigmatism.
- I also consider the long-term trajectory - a patient with well-controlled diabetes and no retinopathy today may have a different retinal status in 10 years, and the lens choice should account for that possibility.
My Retina Training Makes the Difference
Because I am fellowship-trained in retina, I can evaluate diabetic retinopathy, read OCT scans, perform retinal imaging, and make treatment decisions about the retina - not just the cataract. Most cataract surgeons refer diabetic retinopathy management entirely to a retina specialist. I can assess both conditions in one visit, coordinate timing, and make integrated decisions. That means fewer appointments, less coordination confusion, and a surgeon who understands your entire eye at every step.